and methyl (2E)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyacrylate (Azoxystrobin) (CAS No. 131860–33–8) (provided for in subheading 3808.92.15) Free No change No change On or before 12/31/2020 . 836. Oxathiapiprolin Subchapter II of chapter 99 is amended by inserting in numerical sequence the following new heading: 9902.09.47 Mixtures of 1-[4-[4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl]piperidin-1-yl]-2-[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]ethanone (Oxathiapiprolin) (CAS No. 1003318–67–9) (provided for in subheading 3808.92.15) Free No change No change On or before 12/31/2020 . 837. Fluopyram + tebuconazole formulations Subchapter II of chapter 99 is amended by inserting in numerical sequence the following new heading: 9902.09.48 Product mixtures containing N-{2-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]ethyl}-2-(trifluoromethyl)benzamide (Fluopyram) (CAS No. 658066–35–4) and 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol (Tebuconazole) (CAS No. 107534–96–3) (provided for in subheading 3808.92.15) Free No change No change On or before 12/31/2020 . 838. Fluopyram + bacillus firmus formulations Subchapter II of chapter 99 is amended by inserting in numerical sequence the following new heading: 9902.09.49 Product mixtures containing N-[2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethyl]-2-(trifluoromethyl)benzamide (Fluopyram) (CAS No. 658066–35–4) and Bacillus firmus (Strain I-1582) (provided for in subheading 3808.92.15) 0.4% No change No change On or before 12/31/2020 . 839. Prothioconazole + tebuconazole formulations Subchapter II of chapter 99 is amended by inserting in numerical sequence the following new heading: 9902.09.50 Product mixtures containing 2-[(2RS)-2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2H-1,2,4-triazole-3(4H)-thione (Prothioconazole) (CAS No. 178928-70–6) and (RS)-1-p-chlorophenyl-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol (Tebuconazole) (CAS No. 107534–96–3) (provided for in